Wikipedia -WSS

Wikipedia

author：leisure time 2025-09-28 01:39:18 - browse：88

A photo of Robert Blum speaking at the STAT Summit West on May 16, 2024 — Cytokinetics CEO Robert Blum spoke last week at a talk during STAT’s Breakthrough Summit West in San Francisco. Sarah Gonzalez for STAT

Cytokinetics, a drugmaker that is expected to soon launch a promising new heart therapy called aficamten, said Wednesday that it had agreed to pay biotech firm Royalty Pharma a higher royalty on the medicine in return for up to $575 million, which will be used to fund the marketing of the drug and Cytokinetics’ ongoing research and development efforts.

Cytokinetics shares fell nearly 10% in after-hours trading after the announcement, which investors viewed as lowering the odds that the company will be purchased by a larger pharmaceutical company.

The firm also said that it would be raising $500 million through a stock sale.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： Reconstructing family trees of blood cells may help predict disease

WSS

Humana’s losses in Medicare Advantage tank its stock

Why you shouldn’t ask, “What country has the best health care?”

UnitedHealth starts bidding war with $3.3 billion offer for Amedisys

Vertex non

Biogen walks away from Aduhelm, years after polarizing approval

Philips to halt sales of sleep apnea machines in U.S.

Wikipedia

Wikipedia

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

knowledge

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Eating disorder hotline's move to chatbot carried cost for volunteers

Jerome Adams on the need for new antivirals for Covid

Eating disorder hotline's move to chatbot carried cost for volunteers

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Brazil's Jair Bolsonaro is barred from running for office until 2030

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Health Care Service Corp to buy Cigna Medicare Advantage plans

Hollywood unions extend contract negotiations for actors

The simple reason for the increase in autism diagnosis

leisure time

Investment in vaccine development is lagging, report finds

Boston competes with Raleigh

Prince Harry seeks over $550,000 in phone hacking lawsuit against British tabloid publisher

Venture capital firm's plans to take over Akron hospital face hurdles

Newly formed Hurricane Beatriz sweeps close to Mexico's southwest Pacific coast

Eating disorder hotline's move to chatbot carried cost for volunteers

focus

Wikipedia

focus

knowledge